Forglyn Respicap is primarily used for the long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). This combination medicine belongs to two classes of medicines - long-acting beta2-adrenergic receptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs).
In addition to managing COPD, this medicine can also help manage symptoms related to chronic bronchitis and emphysema. However, this medicine is not recommended for the relief of sudden breathing problems or the treatment of asthma.
Before you start taking this medicine, consult your doctor about any pre-existing conditions or ongoing medications. If you notice any side effects while on this medicine, notify your doctor immediately. It's important to continue taking the medicine for the duration prescribed by your doctor for optimal results.